Breaking News

Sanofi-Aventis Deutschland GMBH v. Mylan Pharmaceuticals Inc.

Petition for certiorari denied on October 5, 2020
Docket No. Op. Below Argument Opinion Vote Author Term
19-1451 Fed. Cir. N/A N/A N/A N/A OT 2020

Issues: (1) Whether, in a pending case, a court can refuse to entertain a constitutional, separation-of-powers challenge based on an intervening change of law on the grounds of forfeiture; and (2) whether the U.S. Court of Appeals for the Federal Circuit’s obviousness holding is an unwarranted expansion of the Supreme Court’s decision in KSR International Co. v. Teleflex Inc. and is inconsistent with the Patent Act.

DateProceedings and Orders (key to color coding)
Jun 26 2020Petition for a writ of certiorari filed. (Response due August 3, 2020)
Jul 28 2020Motion to extend the time to file a response from August 3, 2020 to August 24, 2020, submitted to The Clerk.
Jul 29 2020Motion to extend the time to file a response is granted and the time is extended to and including August 24, 2020.
Aug 24 2020Brief of respondent Mylan Pharmaceuticals Inc. in opposition filed.
Sep 08 2020Reply of petitioner Sanofi-Aventis Deutschland GmbH filed. (Distributed)
Sep 09 2020DISTRIBUTED for Conference of 9/29/2020.
Oct 05 2020Petition DENIED.